These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6140029)

  • 21. [The role of the lungs in fat metabolism and its disturbance in silicosis].
    Babushkina LG
    Arkh Patol; 1966; 28(7):3-9. PubMed ID: 4879367
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of the in vitro activity of lysosomal phospholipase A1 by membrane lipids.
    Piret J; Schanck A; Delfosse S; Van Bambeke F; Kishore BK; Tulkens PM; Mingeot-Leclercq MP
    Chem Phys Lipids; 2005 Jan; 133(1):1-15. PubMed ID: 15589222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
    Kacew S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced lipidosis and the alveolar macrophage.
    Reasor MJ
    Toxicology; 1981; 20(1):1-33. PubMed ID: 7022749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysosomal phospholipase A2 and phospholipidosis.
    Hiraoka M; Abe A; Lu Y; Yang K; Han X; Gross RW; Shayman JA
    Mol Cell Biol; 2006 Aug; 26(16):6139-48. PubMed ID: 16880524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized phospholipidosis induced by an amphiphilic cationic psychotropic drug.
    Robison RL; Visscher GE; Roberts SA; Engstrom RG; Hartman HA; Ballard FH
    Toxicol Pathol; 1985; 13(4):335-48. PubMed ID: 3834585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):60-4. PubMed ID: 3941401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of desipramine treatment on pulmonary phospholipid metabolism in rats.
    Yano T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):353-63. PubMed ID: 2385758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of normobaric hyperoxia on lung surfactant phospholipids in rats.
    Ledwozyw A; Borowicz B
    Arch Vet Pol; 1992; 32(3-4):127-33. PubMed ID: 1339568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genesis of foam cells: study in rats after administration of Cloforex.
    Flodh H; Magnusson G
    Virchows Arch B Cell Pathol; 1973 Mar; 12(4):360-6. PubMed ID: 4350410
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipidosis with unusual accumulation of phospholipids and glycolipids. Preliminary note].
    Borri P; Bertinelli RP; Binaglia L
    Acta Neurol (Napoli); 1972; 27(2):167-77. PubMed ID: 5042257
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway.
    Ouyang Q; Huang Z; Lin H; Ni J; Lu H; Chen X; Wang Z; Lin L
    Mol Med Rep; 2015 Aug; 12(2):2589-97. PubMed ID: 25975841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of intranuclear lipids.
    Albi E; Viola Magni MP
    Biol Cell; 2004 Oct; 96(8):657-67. PubMed ID: 15519699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipase A2-mediated release of arachidonic acid in stimulated guinea pig alveolar macrophages: interaction with lipid mediators and cyclic AMP.
    Kadiri C; Masliah J; Bachelet M; Vargaftig BB; Béréziat G
    J Cell Biochem; 1989 Jun; 40(2):157-64. PubMed ID: 2549080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the composition of lung lipids and the "turnover" of dipalmitoyl lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz.
    Heppleston AG; Fletcher K; Wyatt I
    Br J Exp Pathol; 1974 Aug; 55(4):384-95. PubMed ID: 4279687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug-induced lipidosis: formation of myeloid bodies (author's transl)].
    Yamamoto A; Seki K; Kitani T; Matsuzawa Y; Adachi S
    Tanpakushitsu Kakusan Koso; 1974 Apr; 19(4):275-93. PubMed ID: 4369542
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of phospholipids of the pulmonary extracellular lining by electron paramagnetic resonance. The effects of phosphatidylglycerol and unsaturated phosphatidylcholines on the fluidity of dipalmitoyl phosphatidylcholine.
    Hook GE; Spalding JW; Ortner MJ; Tombropoulos EG; Chignell CF
    Biochem J; 1984 Oct; 223(2):533-42. PubMed ID: 6093777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on drug-induced lipidosis. VIII. Correlation between drug accumulation and acidic phospholipids.
    Matsuzawa Y; Yamamoto A; Adachi S; Nishikawa M
    J Biochem; 1977 Nov; 82(5):1369-77. PubMed ID: 412844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.